University of Heidelberg
BIOQUANT

Student posters

International meetings

  • K. Börner, C. Hammerschmidt-Kamper, A. Kretzschmar, E. Fischer, M. Hartmann, P. Schnitzler, H.-G. Kraeusslich, A.-K. Mueller & D. Grimm. "Battle of the midgets - novel insights into the interplay of viruses & pathogens with the host RNAi machinery". Annual meeting of the German Society of Cell Biology (DGZ). Jena, Germany, 2011.
  • D. Niopek & R. Berrens, K. Börner, R. Eils & D. Grimm (on behalf of the iGEM team Heidelberg 2010). "Synthetic miRNA Switches for Deliberate Fine-tuning of Gene Expression". Keystone Symposium on "Mechanisms and Biology of Silencing". Monterey (CA), USA, 2011.
  • S. Mockenhaupt & D. Grimm. "AAV-Mediated shRNA Integration into an Endogenous miRNA Locus as a New Strategy for Safe, Specific and Persistent Therapeutic RNAi". Annual meeting of the American Society of Gene & Cell Therapy (ASGCT). Seattle (WA), USA, 2011.
  • M. Bechtle, E. Kienle, T. Pankert & D. Grimm. "Rational AAV capsid engineering via peptide insertion reveals critical roles of the underlying vector serotype". Annual meeting of the American Society of Gene & Cell Therapy (ASGCT). Seattle (WA), USA, 2011.
  • K. Börner, E. Wiedtke, N. Brown, N. Schürmann, J. Hermle, M. Castoldi, M. Muckenthaler, L. Kaderali, H.-G. Kräusslich & D. Grimm. "Improvement of RNAi screens via stable Ago-2 over-expression". Keystone symposium on "RNA Silencing: Mechanism, Biology and Application". Keystone (CO), USA, 2010.
  • N. Schürmann, E. Wiedtke, G. Meister, L. Wang & D. Grimm. "Directed molecular evolution of chimeric Argonaute proteins as potent new approach to elucidate structure-function relationships of human RISC". Keystone symposium on "RNA Silencing: Mechanism, Biology and Application". Keystone (CO), USA, 2010.
  • K. Börner, E. Fischer, P. Schnitzler, M. Hartmann, H.-G. Kräusslich & D. Grimm. "Blood-borne miRNAs as biomarkers for human HIV-1 infection". The non-coding genome. Heidelberg, Germany, 2010.
  • N. Schürmann, E. Wiedtke & D. Grimm. "Design and pre-clinical evaluation of Adeno-associated viral (AAV) vectors for therapeutic inhibition of disease-associated miRNA". Annual meeting of the American Society of Gene & Cell therapy (ASGCT). Washington (DC), USA, 2010.
  • D. Niopek & A. Mathur, R. Eils & D. Grimm (on behalf of the iGEM team Heidelberg 2010). "miBricks- DNA is not enough". International genetically engineered machines competition (iGEM). Boston (MA), USA, 2010.
  • S. Mockenhaupt, N. Schürmann & D. Grimm. "Alleviation of adverse shRNA off-targeting via AAV-vector encoded passenger strand decoys". Keystone symposium on RNA Silencing: Mechanism, Biology and Application. Keystone (CO), USA, 2010.
  • E. Kienle, D. Grimm, A. Weith, J. Rippman & S. Kreuz. "Artificial AAV capsid libraries as a source for AAV vectors with novel transduction characteristics". Boehringer Ingelheim International Biology Meeting. Sonnthohen, Germany, 2009.
  • N. Schürmann, L. S. Wang, E. Hoffmann & D. Grimm. "Design and pre-clinical evaluation of Adeno-associated viral (AAV) vectors for quantitative inhibition of miRNAs (AAV-MISP) in vitro and in vivo". Keystone symposium on Biology of RNA Silencing. Victoria, CA, 2009.

National meetings

  • N. Schürmann, E. Wiedtke, S. Kallis, M. Binder, R. Bartenschlager & D. Grimm. "Design and pre-clinical evaluation of Adeno-associated viral (AAV) vectors for therapeutic inhibition of disease-associated miRNAs". 21st Annual Meeting of the "Gesellschaft für Virologie". Freiburg, Germany, 2011.
  • E. Kienle, E. Hoffmann & D. Grimm. "AAV vector evolution". HBIGS First Annual Review Meeting. Heidelberg, Germany, 2009.
Contact: E-Mail (Last update: 16/02/2012)